NPCS has been helping entrepreneurs, startups, MSMEs, and industrial investors since 1992 with detailed project reports, feasibility studies, market research, and business consulting services across 50+ industries.
Every surgery, every diagnostic test, every dental procedure begins with the same small ritual — a fresh pair of gloves. That single habit, repeated millions of times a day across the world's hospitals, has turned surgical latex and nitrile gloves into one of the most dependable consumables in healthcare. For a startup looking for a product with guaranteed repeat demand, few manufacturing ideas offer this kind of built-in consumption cycle.
Market Overview and Size
The global surgical gloves market stands at around USD 5.26 billion in 2026 and is projected to touch USD 6.54 billion by 2031, growing at a steady 4.4% CAGR. The nitrile segment is the real growth engine: the global nitrile gloves market, valued near USD 5.7 billion in 2026, is expected to nearly double to USD 11 billion by 2033 at 9.9% CAGR, driven by latex-allergy concerns and superior chemical and puncture resistance.
India's story is even more compelling. The domestic surgical gloves market generated roughly USD 84 million in 2025 and is forecast to reach about USD 163 million by 2033 at 8.7% CAGR — making India the fastest-growing market in Asia Pacific. In nitrile gloves specifically, India leads all major countries with an estimated 11.3% CAGR through 2036.
Trends Shaping the Industry
Three shifts stand out. First, powder-free gloves now command over 85% of the market following regulatory bans on powdered variants. Second, nitrile continues to displace natural latex in hospitals because it eliminates protein-allergy risk while matching tactile performance. Third, innovation is moving toward accelerator-free and thin-gauge, high-sensitivity formulations — Indian firms have already launched accelerator-free nitrile gloves meeting EN 455 and ISO 13485 standards.
Export Potential
Malaysia and Thailand dominate global supply today, but international buyers are actively diversifying sourcing after pandemic-era disruptions — a genuine window for Indian manufacturers. India still imports a substantial volume of surgical gloves and nitrile raw materials, so a new unit enjoys a double opportunity: import substitution at home and exports to the US, EU, Middle East and Africa, where infection-control mandates keep demand rising. CE marking, US FDA 510(k) clearance and ISO 13485 certification open these markets.
Why Entrepreneurs Should Invest
Major Players
Indian manufacturers include Kanam Latex Industries, Primus Gloves, RFB Latex, Mallcom (India) and Sara Healthcare. Global leaders are Top Glove, Hartalega, Kossan and Supermax (Malaysia), Ansell (Australia) and INTCO Medical (China).
The Bottom Line
Strong domestic growth, an open export window and policy tailwinds make surgical latex and nitrile glove manufacturing a genuinely bankable venture. NPCS can support entrepreneurs with detailed project reports, techno-economic feasibility studies and market surveys to take this idea from concept to commissioning.
| Plant capacity | Plant & machinery | Working capital | Cost of Project | T.C.I | Return | Break even |
|---|---|---|---|---|---|---|
| Surgical Latex Gloves (4gm ± 0.02gm) each: 1,25,000 Pcs Per Day Nitrile Gloves (Powder Free) (5.5gm ± 0.02gm) each: 1,25,000 Pcs Per Day | 823 | N/A | 2226 | 30 | 43 |
Entrepreneur India, an Industrial monthly magazine on industrial development, technologies & project opportunities aims at simplifying the process of choosing the suitable project for investment.
Entrepreneur India - Copyright 2017-. All rights reserved.
